While tennis star Sharapova fights her two-year doping ban, she’s decided to keep herself busy in the interim by enrolling in the Harvard Business School.
The ruling on the Sharapova case by CAS is expected by July 18, but the tennis player is not wasting time sitting on the sidelines.
For someone who has displayed great business acumen off the court throughout her career, it seems she’s now going to have a degree to show for it.
The International Tennis Federation (ITF) banned the 29-year-old Russian in June, after a positive test for the banned substance meldonium during January’s Australian Open.
Almost 200 athletes have tested positive for meldonium so far this year, after the drug was placed on the banned list by WADA (World Anti-Doping Agency) in January.
The five-time grand slam champion’s appeal to the Court of Arbitration for Sport (CAS) was filed earlier in June with the goal of either reducing or completely eliminating the ban.
